Clinical Trial Update: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating chemotherapy plus bone marrow transplantation in patients with refractory non-Hodgkin lymphoma, Hodgkin lymphoma, or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED